We are live on ! Find out more
Nicholas Company

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+3.67%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.5B
AUM Growth
+$94.9M
Cap. Flow
-$25.6M
Cap. Flow %
-0.57%
Top 10 Hldgs %
21.03%
Holding
225
New
17
Increased
85
Reduced
77
Closed
10
Avg Time Held
2.2 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
1.7 years

Top Buys

Rank Stock Value
1
FAST icon
Fastenal
FAST
+$35.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$21M
3
KDP icon
Keurig Dr Pepper
KDP
+$20.3M
4
EFX icon
Equifax
EFX
+$17.3M
5
EWBC icon
East-West Bancorp
EWBC
+$13.4M

Top Sells

Rank Stock Value
1
DVA icon
DaVita
DVA
+$42.1M
2
GWW icon
W.W. Grainger
GWW
+$41.1M
3
ABBV icon
AbbVie
ABBV
+$35.2M
4
SWKS icon
Skyworks Solutions
SWKS
+$25.8M
5
PNRA
Panera Bread Co
PNRA
+$11.9M

Sector Composition

Rank Sector Weight
1 Healthcare 21.03%
2 Technology 17.98%
3 Financials 15.03%
4 Industrials 14.79%
5 Consumer Discretionary 13.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MELI icon
76
Mercado Libre
MELI
$94.1B
$13.2M 0.29%
52,775
-21,630
-29% -$5.56M
2013 Q2
16 quarters
RJF icon
77
Raymond James Financial
RJF
$30.3B
$13.1M 0.29%
245,738
+72,210
+42% +$3.63M
2013 Q2
16 quarters
COO icon
78
Cooper Companies
COO
$10.9B
$13.1M 0.29%
218,840
-1,200
-0.5% -$65.2K
2013 Q2
16 quarters
IEX icon
79
IDEX
IEX
$17.4B
$12.9M 0.29%
114,360
-20,115
-15% -$2.11M
2013 Q2
16 quarters
ABT icon
80
Abbott
ABT
$181B
$12.9M 0.29%
265,265
+890
+0.3% +$40.3K
2013 Q2
16 quarters
LIVN icon
81
LivaNova
LIVN
$4.32B
$12.7M 0.28%
208,190
+110,750
+114% +$6.26M
2015 Q4
6 quarters
WTW icon
82
Willis Towers Watson
WTW
$28.8B
$12.7M 0.28%
87,432
-68,808
-44% -$9.61M
2013 Q2
16 quarters
AME icon
83
Ametek
AME
$57B
$12.6M 0.28%
208,710
-30,125
-13% -$1.78M
2013 Q2
16 quarters
ODFL icon
84
Old Dominion Freight Line
ODFL
$39.2B
$12.5M 0.28%
392,355
+225
+0.1% +$6.62K
2016 Q2
4 quarters
PSMT icon
85
Pricesmart
PSMT
$5.24B
$12.4M 0.28%
141,825
+85
+0.1% +$7.47K
2013 Q2
16 quarters
FISV icon
86
Fiserv Inc
FISV
$25.1B
$12.2M 0.27%
199,898
– –
2013 Q2
16 quarters
NUVA
87
DELISTED
NuVasive, Inc.
NUVA
$12.1M 0.27%
157,330
+77,680
+98% +$5.81M
2015 Q3
7 quarters
WPC icon
88
W.P. Carey
WPC
$14.7B
$12M 0.27%
186,149
-7,667
-4% -$485K
2013 Q2
16 quarters
CDW icon
89
CDW
CDW
$19.3B
$12M 0.27%
191,935
-85
-0% -$5.08K
2014 Q3
11 quarters
XRAY icon
90
Dentsply Sirona
XRAY
$1.76B
$11.8M 0.26%
181,225
+220
+0.1% +$13.9K
2013 Q2
16 quarters
CCK icon
91
Crown Holdings
CCK
$12.4B
$11.7M 0.26%
195,290
+90
+0% +$5.08K
2016 Q2
4 quarters
R icon
92
Ryder
R
$9.21B
$11.6M 0.26%
160,985
-70
-0% -$4.84K
2013 Q2
16 quarters
TRU icon
93
TransUnion
TRU
$14.2B
$11.5M 0.26%
+266,625
New +$11M
2017 Q2
0 quarters
LW icon
94
Lamb Weston
LW
$7.47B
$11.3M 0.25%
256,645
+45,270
+21% +$1.99M
2017 Q1
1 quarter
STZ icon
95
Constellation Brands
STZ
$21.9B
$11.2M 0.25%
57,835
+5
+0% +$890
2016 Q1
5 quarters
WY icon
96
Weyerhaeuser
WY
$14B
$11M 0.24%
327,280
+31,660
+11% +$1.07M
2017 Q1
1 quarter
SEIC icon
97
SEI Investments
SEIC
$12.6B
$10.8M 0.24%
201,200
– –
2016 Q1
5 quarters
IQV icon
98
IQVIA
IQV
$44.6B
$10.8M 0.24%
120,475
-1,600
-1% -$135K
2016 Q4
2 quarters
CDK
99
DELISTED
CDK Global, Inc.
CDK
$10.6M 0.24%
171,045
+90
+0.1% +$5.64K
2014 Q4
10 quarters
AGN.PRA
100
DELISTED
Allergan plc
AGN.PRA
$10.6M 0.24%
12,265
-5
-0% -$4.19K
2016 Q4
2 quarters
2 3
4
5 6

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EFG International
EFG International Zurich $5.46B AUM
Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Exor N.V.
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Voleon Capital Management
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
Glenview Capital Management
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TD Private Client Wealth
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q2 2017 Portfolio in Review

As of Q2 2017, Nicholas Company held 225 positions worth $4.5B, up 2.2% from $4.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Company's Q2 2017 filing shows 17 new, 85 increased, 77 reduced and 10 closed positions. Its largest new stake was Keurig Dr Pepper: 216,925 shares worth $19.8M. The largest sale was DaVita, an estimated $42.1M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

  • Nicholas Company's largest Q2 2017 buy was Keurig Dr Pepper: 216,925 shares worth $19.8M.
  • Nicholas Company added most to Fastenal in Q2 2017, an estimated $35.3M increase.
  • Nicholas Company's biggest Q2 2017 reduction was DaVita, cutting an estimated $42.1M.
  • Nicholas Company fully exited AbbVie in Q2 2017, selling an estimated $35.2M.
  • Nicholas Company's ten largest holdings make up 21% of its $4.5B portfolio in Q2 2017.
  • Nicholas Company opened 17 new positions and closed 10 in Q2 2017.
  • Nicholas Company's portfolio value rose 2.2% quarter-over-quarter to $4.5B.

Based on Nicholas Company's 13F filing for Q2 2017, filed 11 Aug 2017.